Michael A Carducci



Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michael A Carducci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

    Hasan, H., Deek, M. P., Phillips, R., Hobbs, R. F., Malek, R., Radwan, N., Kiess, A. P., Dipasquale, S., Huang, J., Caldwell, T., Leitzel, J., Wendler, D., Wang, H., Thompson, E., Powell, J., Dudley, S., Deville, C., Greco, S. C., Song, D. Y., Deweese, T. L. & 11 others, Gorin, M. A., Rowe, S. P., Denmeade, S., Markowski, M., Antonarakis, E. S., Carducci, M. A., Eisenberger, M. A., Pomper, M. G., Pienta, K. J., Paller, C. J. & Tran, P. T., Jun 1 2020, In : BMC cancer. 20, 1, 492.

    Research output: Contribution to journalArticle

    Open Access
  • HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

    Hearn, J. W. D., Sweeney, C. J., Almassi, N., Reichard, C. A., Reddy, C. A., Li, H., Hobbs, B., Jarrard, D. F., Chen, Y. H., Dreicer, R., Garcia, J. A., Carducci, M. A., Dipaola, R. S. & Sharifi, N., Apr 2020, In : JAMA Oncology. 6, 4, e196496.

    Research output: Contribution to journalArticle

  • Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

    Phillips, R., Shi, W. Y., Deek, M., Radwan, N., Lim, S. J., Antonarakis, E. S., Rowe, S. P., Ross, A. E., Gorin, M. A., Deville, C., Greco, S. C., Wang, H., Denmeade, S. R., Paller, C. J., Dipasquale, S., Deweese, T. L., Song, D. Y., Wang, H., Carducci, M. A., Pienta, K. J. & 6 others, Pomper, M. G., Dicker, A. P., Eisenberger, M. A., Alizadeh, A. A., Diehn, M. & Tran, P. T., May 2020, In : JAMA Oncology. 6, 5, p. 650-659 10 p.

    Research output: Contribution to journalArticle

    Open Access